These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 20201352)

  • 1. [Endomorphins--endogenous ligands of the mu-opioid receptor].
    Perlikowska R; Fichna J; Janecka A
    Postepy Biochem; 2009; 55(4):388-94. PubMed ID: 20201352
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endomorphins and related opioid peptides.
    Okada Y; Tsuda Y; Bryant SD; Lazarus LH
    Vitam Horm; 2002; 65():257-79. PubMed ID: 12481550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Opioids in chronic pain.
    Przewłocki R; Przewłocka B
    Eur J Pharmacol; 2001 Oct; 429(1-3):79-91. PubMed ID: 11698029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel non-opioid binding site for endomorphin-1.
    Lengyel I; Toth F; Biyashev D; Szatmari I; Monory K; Tomboly C; Toth G; Benyhe S; Borsodi A
    J Physiol Pharmacol; 2016 Aug; 67(4):605-616. PubMed ID: 27779481
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enzymatic degradation of endomorphins.
    Janecka A; Staniszewska R; Gach K; Fichna J
    Peptides; 2008 Nov; 29(11):2066-73. PubMed ID: 18718496
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Endomorphins: structure, localization, immunoregulatory activity].
    Gein SV; Baeva TA
    Probl Endokrinol (Mosk); 2020 Aug; 66(1):78-86. PubMed ID: 33351316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endomorphin 1 activates nitric oxide synthase 2 activity and downregulates nitric oxide synthase 2 mRNA expression.
    Sarić A; Balog T; Sobocanec S; Marotti T
    Neuroscience; 2007 Feb; 144(4):1454-61. PubMed ID: 17197099
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological characterization of endomorphin-1 and endomorphin-2 in mouse brain.
    Goldberg IE; Rossi GC; Letchworth SR; Mathis JP; Ryan-Moro J; Leventhal L; Su W; Emmel D; Bolan EA; Pasternak GW
    J Pharmacol Exp Ther; 1998 Aug; 286(2):1007-13. PubMed ID: 9694962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Possible involvement of dynorphin A-(1-17) release via mu1-opioid receptors in spinal antinociception by endomorphin-2.
    Mizoguchi H; Watanabe H; Hayashi T; Sakurada W; Sawai T; Fujimura T; Sakurada T; Sakurada S
    J Pharmacol Exp Ther; 2006 Apr; 317(1):362-8. PubMed ID: 16394196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro characterization of novel peptide inhibitors of endomorphin-degrading enzymes in the rat brain.
    Fichna J; Janecka A; Bailly L; Marsais F; Costentin J; do Rego JC
    Chem Biol Drug Des; 2006 Sep; 68(3):173-5. PubMed ID: 17062015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The endomorphin-1/2 and dynorphin-B peptides display biased agonism at the mu opioid receptor.
    LaVigne J; Keresztes A; Chiem D; Streicher JM
    Pharmacol Rep; 2020 Apr; 72(2):465-471. PubMed ID: 32112361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isolation of relatively large amounts of endomorphin-1 and endomorphin-2 from human brain cortex.
    Hackler L; Zadina JE; Ge LJ; Kastin AJ
    Peptides; 1997; 18(10):1635-9. PubMed ID: 9437727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The endogenous mu-opioid receptor agonists endomorphins 1 and 2 have novel hypotensive activity in the rabbit.
    Champion HC; Zadina JE; Kastin AJ; Hackler L; Ge LJ; Kadowitz PJ
    Biochem Biophys Res Commun; 1997 Jun; 235(3):567-70. PubMed ID: 9207197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endomorphin-1 and endomorphin-2 show differences in their activation of mu opioid receptor-regulated G proteins in supraspinal antinociception in mice.
    Sánchez-Blázquez P; Rodríguez-Díaz M; DeAntonio I; Garzón J
    J Pharmacol Exp Ther; 1999 Oct; 291(1):12-8. PubMed ID: 10490881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anatomical and functional correlation of the endomorphins with mu opioid receptor splice variants.
    Abbadie C; Rossi GC; Orciuolo A; Zadina JE; Pasternak GW
    Eur J Neurosci; 2002 Sep; 16(6):1075-82. PubMed ID: 12383236
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Saturable brain-to-blood transport of endomorphins.
    Kastin AJ; Fasold MB; Smith RR; Horner KA; Zadina JE
    Exp Brain Res; 2001 Jul; 139(1):70-5. PubMed ID: 11482845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Opioid receptors and their selective ligands].
    Piestrzeniewicz MK; Fichna J; Janecka A
    Postepy Biochem; 2006; 52(3):313-9. PubMed ID: 17201067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclic endomorphin analogs in targeting opioid receptors to achieve pain relief.
    Janecka A; Gentilucci L
    Future Med Chem; 2014; 6(18):2093-101. PubMed ID: 25531970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endomorphin derivatives with improved pharmacological properties.
    Varamini P; Blanchfield JT; Toth I
    Curr Med Chem; 2013; 20(22):2741-58. PubMed ID: 23590712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Possible involvement of dynorphin A release via mu1-opioid receptor on supraspinal antinociception of endomorphin-2.
    Sakurada S; Sawai T; Mizoguchi H; Watanabe H; Watanabe C; Yonezawa A; Morimoto M; Sato T; Komatsu T; Sakurada T
    Peptides; 2008 Sep; 29(9):1554-60. PubMed ID: 18571771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.